L-NAME in the cardiovascular system - nitric oxide synthase activator?

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 3

Abstract

L-arginine analogues are widely used inhibitors of nitric oxide synthase (NOS) activity both in vitro and in vivo, with N(ω)-nitro-L-arginine methyl ester (L-NAME) being at the head. On the one hand, acute and chronic L-NAME treatment leads to changes in blood pressure and vascular reactivity due to decreased nitric oxide (NO) bioavailability. However, lower doses of L-NAME may also activate NO production via feedback regulatory mechanisms if administered for longer time. Such L-NAME-induced activation has been observed in both NOS expression and activity and revealed considerable differences in regulatory mechanisms of NO production between particular tissues depending on the amount of L-NAME. Moreover, feedback activation of NO production by L-NAME seems to be regulated diversely under conditions of hypertension. This review summarizes the mechanisms of NOS regulation in order to better understand the apparent discrepancies found in the current literature.

Authors and Affiliations

Jana Kopincová, Angelika Púzserová, Iveta Bernátová

Keywords

Related Articles

Reductive metabolism of the sanguinarine iminium bond by rat liver preparations.

Background: Sanguinarine (SA) is a quaternary benzo[c]phenanthridine alkaloid that is mainly present in the Papaveraceae family. SA has been extensively studied because of its antimicrobial, anti-inflammatory, antitumor,...

Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.

Available propofol pharmacokinetic protocols for target-controlled infusion (TCI) were obtained from healthy individuals. However, the disposition as well as the response to a given drug may be altered in clinical condit...

EP₃ receptor-mediated contraction of human pulmonary arteries and inhibition of neurogenic tachycardia in pithed rats.

The aim of our study was (1) the pharmacological characterization of EP(3) receptors in human pulmonary arteries and (2) the examination of the potential involvement of these receptors in the regulation of neurogenic tac...

Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy ((1)H MRS) in children with Down syndrome.

Down syndrome (DS), or trisomy 21, is one of the most common autosomal mutations. The overexpression of the β-amyloid precursor protein gene, located on chromosome 21, causes an increased production of the specific amylo...

Study of the protective effect of calcium channel blockers against neuronal damage induced by glutamate in cultured hippocampal neurons.

Background: The aim of this study was to examine the putative protective effect of calcium channel blockers on hippocampal neurons in the experimental model of excitotoxic damage. Methods: Seven-day old primary dissociat...

Download PDF file
  • EP ID EP92792
  • DOI -
  • Views 133
  • Downloads 0

How To Cite

Jana Kopincová, Angelika Púzserová, Iveta Bernátová (2012). L-NAME in the cardiovascular system - nitric oxide synthase activator?. Pharmacological Reports, 64(3), 511-520. https://www.europub.co.uk/articles/-A-92792